LANNETT CO INC FDA Approval ANDA 091288

ANDA 091288

LANNETT CO INC

FDA Drug Application

Application #091288

Application Sponsors

ANDA 091288LANNETT CO INC

Marketing Status

Prescription001

Application Products

001SYRUP;ORALEQ 15MG BASE/ML0RANITIDINE HYDROCHLORIDERANITIDINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2010-12-09

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAA

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91288
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"RANITIDINE HYDROCHLORIDE","activeIngredients":"RANITIDINE HYDROCHLORIDE","strength":"EQ 15MG BASE\/ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"RANITIDINE HYDROCHLORIDE","submission":"RANITIDINE HYDROCHLORIDE","actionType":"EQ 15MG BASE\/ML","submissionClassification":"SYRUP;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.